A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents : Raltegravir, maraviroc, darunavir, and etravirine
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-04-15
著者
-
Buclin T.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Rochat B.
Plate-forme De Spectrometrie De Masse Department De Recherche Centre Hospitalier Universitaire Vaudo
-
Beguin A.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Decosterd L.
Division Of Clinical Pharmacology Department Of Internal Medicine Bh 18-lab 218 Centre Hospitalier U
-
Decosterd L.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Biollaz J.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Guignard N.
Division De Pharmacologie Clinique Department De Medicine Laboratoire Bh 18-218 Centre Hospitalier U
-
Rochat B.
Quantitative Mass Spectrometry Facility Of The Chromatography-mass Spectrometry Platform Of The Univ
-
Decosterd L.
Division De Pharmacologie Clinique Department De Medicine Laboratoire Bh 18-218 Centre Hospitalier U
-
Telenti A.
Institute Of Microbiology University Hospital Of Lausanne
-
ZANOLARI B.
Division de Pharmacologie clinique, Department de Medicine, Centre Hospitalier Universitaire Vaudois
-
FAYET A.
Division of Clinical Pharmacology and Toxicology, University Hospital of Lausanne
-
CRUCHON S.
Division of Clinical Pharmacology and Toxicology, University Hospital of Lausanne
-
CAVASSINI M.
Service of Infectious Diseases, University Hospital of Lausanne
-
GUNTHARD H.
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich
-
Cavassini M.
Service Of Infectious Diseases University Hospital Of Lausanne
-
Cruchon S.
Division Of Clinical Pharmacology And Toxicology Department Of Medicine Lausanne Centre Hospitalier
-
Fayet A.
Division Of Clinical Pharmacology And Toxicology University Hospital Of Lausanne
-
Gunthard H.
Division Of Infectious Diseases And Hospital Epidemiology University Hospital Zurich
-
Zanolari B.
Division Of Clinical Pharmacology And Toxicology Department Of Medicine Lausanne Centre Hospitalier
-
Zanolari B.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois A
関連論文
- Determination of imatinib (Gleevec^【○!R】) in human plasma by solid-phase extraction-liquid chromatography-ultraviolet absorbance detection
- Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry
- Determination of aciclovir and ganciclovir in human plasma by liquid chromatography-spectrofluorimetric detection and stability studies in blood samples
- Determination of the novel non-peptidic HIV-protease inhibitor tipranavir by HPLC-UV after solid-phase extraction
- Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction
- High-performance liquid chromatography of the renal blood flow marker p-aminohippuric acid (PAH) and its metabolite N-acetyl PAH improves PAH clearance measurements
- Determination of temozolomide in human plasma and urine by high-performance liquid chromatography after solid-phase extraction
- Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry
- A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents : Raltegravir, maraviroc, darunavir, and etravirine
- An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma : First evidence of 4'-hydroxylated metabolites in breast cancer patients
- A single LC-tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma